Clinical trial

Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

NCT04191577

Study summary

ClinicalTrials.gov

Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention CVN424 Low Dose Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention CVN424 High Dose Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-12-02

PhasePHASE2

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

CVN424 Low DoseDRUG

CVN424 High DoseDRUG

PlaceboDRUG

Sponsors & collaborators

Cerevance Beta, Inc.lead sponsor

Mapped research locations

New YorkNew York, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1 ColumbusOhio, United States1 TampaFlorida, United States1 Long BeachCalifornia, United States1 Kansas CityKansas, United States1 SpokaneWashington, United States1 GreenvilleSouth Carolina, United States1 RaleighNorth Carolina, United States1 DaytonOhio, United States1 Boca RatonFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04191577 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.